08.01.2015 Views

WATER ABLAZE - Patagonia Sin Represas

WATER ABLAZE - Patagonia Sin Represas

WATER ABLAZE - Patagonia Sin Represas

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

existence today, WIPO has dwindled in importance on account of<br />

TRIPS because the latter adheres more closely to WTO principles<br />

and is therefore more able to represent the interests of the industrial<br />

nations on account of its greater assertiveness. The European Patent<br />

Office (EPO), which has its headquarters in Munich, can be regarded<br />

as TRIPS’ European counterpart and very much the equal of the two<br />

organisations mentioned above with regard to its submissiveness to<br />

corporate desires.<br />

The dawn of genetic engineering brought with it a drastic increase<br />

in the number of applications for patents on living things, plants,<br />

organisms or seeds. By the end of 2007, more than 65,000 applications<br />

from the field of genetic engineering had been submitted to the<br />

European Patent Office. Worldwide, almost 20,000 patents on human<br />

genes have been applied for, 2,670 of which have already been granted<br />

by the EPO. Of the 5,500 or so patent applications on animals, 667<br />

have likewise been successful. More than 6,000 applications are related<br />

to plants and 1,000 of these patents have already been issued.<br />

The EPO granted a patent on pig-breeding to the U.S. corporation<br />

Monsanto. It involves a method of breeding using a normal pig’s gene<br />

and its variants, in order to breed pigs with greater feed conversion<br />

efficiency. The patentee is entitled to claim fees not only for the use of<br />

the methods, but also for the animals themselves and their offspring.<br />

In January 2007, the EPO issued two patents on transgenic cows<br />

with increased milk production (EP 1330552), this time involving a key<br />

enzyme in the lipometabolism process, diacylglycerol acyltransferase.<br />

Likewise in 2007, the U.S. company Pioneer was granted a patent on<br />

a sunflower variety (EP 1465475 B1). The patented sunflowers were<br />

not even genetically modified, their hereditary factors simply revealed<br />

a higher resistance against a certain parasite in the soil which can<br />

damage the roots. “Normal” broccoli, too, has already been patented<br />

(EP 1069819 B1) and the list could be continued ad infinitum. Via<br />

international agreements, such as the Convention on Biological<br />

Diversity (CBD) or the Union for the Protection of Plant Varieties<br />

(UPOV), attempts are being made to secure a fairer distribution of<br />

genetic resources. The EPO itself mentions limits to the patentability<br />

160

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!